AMP Capital Investors Ltd boosted its position in Waters Co. (NYSE:WAT) by 1.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,494 shares of the medical instruments supplier’s stock after purchasing an additional 500 shares during the quarter. AMP Capital Investors Ltd’s holdings in Waters were worth $6,278,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brown Advisory Securities LLC purchased a new stake in Waters in the 4th quarter worth approximately $202,000. Checchi Capital Advisers LLC purchased a new stake in Waters in the 4th quarter worth approximately $210,000. Trust Co. of Virginia VA purchased a new stake in Waters in the 4th quarter worth approximately $213,000. Zions Bancorporation lifted its stake in Waters by 12,075.0% in the 3rd quarter. Zions Bancorporation now owns 1,461 shares of the medical instruments supplier’s stock worth $262,000 after purchasing an additional 1,449 shares in the last quarter. Finally, Contravisory Investment Management Inc. purchased a new stake in Waters in the 4th quarter worth approximately $290,000. Institutional investors and hedge funds own 94.96% of the company’s stock.
Shares of Waters Co. (NYSE:WAT) opened at $213.18 on Friday. The company has a current ratio of 7.04, a quick ratio of 6.60 and a debt-to-equity ratio of 0.85. The firm has a market cap of $16,729.09, a price-to-earnings ratio of 1,122.06, a PEG ratio of 2.54 and a beta of 0.91. Waters Co. has a 52-week low of $153.04 and a 52-week high of $220.20.
Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.44 by $0.07. Waters had a net margin of 0.88% and a return on equity of 24.70%. The firm had revenue of $687.28 million for the quarter, compared to analysts’ expectations of $671.98 million. During the same quarter last year, the company posted $2.21 EPS. The business’s quarterly revenue was up 9.3% on a year-over-year basis. sell-side analysts expect that Waters Co. will post 8.16 earnings per share for the current year.
In related news, SVP Elizabeth B. Rae sold 28,400 shares of the stock in a transaction on Monday, January 29th. The shares were sold at an average price of $219.01, for a total transaction of $6,219,884.00. Following the transaction, the senior vice president now owns 13,443 shares of the company’s stock, valued at approximately $2,944,151.43. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Joann A. Reed sold 1,386 shares of the stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $194.07, for a total transaction of $268,981.02. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 75,180 shares of company stock worth $16,326,519. 5.07% of the stock is owned by insiders.
Several analysts have issued reports on the stock. ValuEngine cut shares of Waters from a “buy” rating to a “hold” rating in a research note on Wednesday, March 7th. JPMorgan Chase & Co. increased their target price on shares of Waters from $180.00 to $200.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 24th. Citigroup increased their target price on shares of Waters from $190.00 to $223.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 24th. William Blair reiterated an “outperform” rating on shares of Waters in a research note on Tuesday, January 23rd. Finally, Barclays increased their target price on shares of Waters from $202.00 to $208.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 24th. Thirteen investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $203.75.
ILLEGAL ACTIVITY NOTICE: This story was first reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://ledgergazette.com/2018/03/18/waters-co-wat-holdings-increased-by-amp-capital-investors-ltd.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.